IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma

The current World Health Organization (WHO) classification of human gliomas is mainly based on morphology. However, it has limitations in prognostic prediction. We examined whether combining isocitrate dehydrogenase (IDH) 1/2 mutation status with the Ki-67 labeling index would improve the definition...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ailiang, Hu, Qi, Liu, Yanwei, Wang, Zheng, Cui, Xiaoming, Li, Rui, Yan, Wei, You, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745793/
https://www.ncbi.nlm.nih.gov/pubmed/26338964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745793/
https://www.ncbi.nlm.nih.gov/pubmed/26338964

Ejemplares similares